|
|
News Breaks
|
January 23, 2012
|
| 07:38 EDT |  | FMS, MDCO |
| theflyonthewall.com: | APP Pharmaceuticals announces settlement with The Medicines Co. | | APP Pharmaceuticals, a Fresenius Kabi Company (FMS), announced that it has settled its litigation with The Medicines Company (MDCO) relating to APP’s Abbreviated New Drug Application for a generic version of the anti-clotting drug Angiomax. Under the settlement, The Medicines Company has licensed APP to begin selling APP’s generic version of Angiomax in the U.S. on May 1, 2019. Furthermore, in certain limited circumstances, The Medicines Company’s license to APP would become effective prior to May 1, 2019, and may include the right to market an authorized generic bivalirudin product supplied by The Medicines Company. :theflyonthewall.com |
|
|
News For FMS;MDCO From The Last 14 Days Check below for free stories on FMS;MDCO the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 15, 2012
|
| 16:56 EDT | | MDCO |
| theflyonthewall.com: | Soros reports decreased stakes in InterOil, Motorola, Medicines Co, Wells Fargo |
 Subscribe for More Information :theflyonthewall.com |
|
|
|
|
|
